Shian-Jiun Shih

Dr. Shih has over 20 years of experience in the biopharmaceutical industry, with strong expertise in biological drug development, including cell and gene therapy products and therapeutic proteins, with a focus on immunotherapy. Prior to joining Tessa, she was Director of Molecular Biomarkers and Site Lead of the Translational Medicine and Research Centre, Merck Sharp & Dohme. In that role, her group established non-human primate disease models and developed clinical biomarker assays to support early phase clinical trials, including those for Keytruda. Before that she was Director, Assay Development, Cell Genesys, Inc. She has also held various roles in Bayer, Aventis, and Applied Immune Sciences. Dr. Shih is Founding President of the Chinese Bioscience Association. She holds a Ph.D. in Biochemistry from University of Wisconsin at Madison and completed her post-doctoral training at the School of Medicine, Stanford University.

Shian-Jiun Shih is the Vice President of Product Development at Tessa Therapeutics, based in United States, North America. With a background in Biotechnology, Shian-Jiun Shih has a rich history of leadership and innovation.Shian-Jiun Shih studied B.A Chemistry at National Taiwan University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.